Contract Services Contract Manufacturing

Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment ...

 October 13, 2021 | News

Catalent Opens New Full-Service Clinical Supply Facility in Shiga, Japan

The 6,000 square-meter site will provide flexible clinical supply solutions, serving both local and global biotech and pharmaceutical companies. The facili...

 October 10, 2021 | News

Vetter/Syntegon partnership scores PDA Drug Delivery Innovation Award

With demand for niche and orphan drugs continuing to surge, Vetter and Syntegon recently synced their expertise to advance the industry’s approach to...

 October 07, 2021 | News

CPhI Report predicts record EBITDAs for CDMOs in 2022

Part one of the 2021 CPhI Annual Report predicts an increasingly bullish outlook for CDMOs in the next 2-3 years, with macro factors significantl...

 September 28, 2021 | News

Samsung Biologics introduced its CDO process platform, S-Cellerate(TM), at BPI 2021

Samsung Biologics, a global contract development and manufacturing organization (CDMO), introduced its proprietary technology platform, S-CellerateTM, at t...

 September 23, 2021 | News

WuXi Biologics Completes SARS-CoV-2 Protein Synthesis for BVX-0320 and CoviDTH

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys"), announced that CDMO's global partner WuXi Biologics has completed the syn...

 September 15, 2021 | News

GenScript ProBio to Manufacture Innovative Antibody Drug

FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the treatment of acute myeloid leukemia (AML) patients in complete remission. FLYSYN wa...

 September 06, 2021 | News

WuXi Biologics Received First Manufacturing License from Japan

WuXi Biologics (WuXi Bio) , a global company with leading open-access biologics technology platforms, today announced that it has received the Manufacturin...

 September 02, 2021 | News

WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate

This additional EMA GMP certificate was issued following a remote inspection conducted by Poland's Chief Pharmaceutical Inspectorate in Apri...

 August 03, 2021 | News

CliniRx to offer full suite of Rave EDC and CDM services to sponsors

 CliniRx has achieved accreditation as a CRO partner for Medidata Rave EDC, joining Medidata's industry-leading partner program to furt...

 July 30, 2021 | News

Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility

Marker Therapeutics, Inc.  a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapi...

 July 30, 2021 | News

WuXi Biologics Received First GMP manufacturing authorization outside of China

First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quality system Only 12 months from facility qualific...

 July 26, 2021 | News

Vetter Site status now ‘ready for media fill’

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) has further invested in additional capacity to meet this growin...

 July 21, 2021 | News

Samsung Biologics and Kineta Announce CDMO Agreement

Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12.1 to IND Samsung Biologics San Francisco R&D cent...

 July 21, 2021 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in